Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Thin on the Outside, Metabolic on the Inside: Oral GLP-1s, Hormones, and a New Era for South Asian Women | Endocrine Matters Ep. 2.52 cover art

Thin on the Outside, Metabolic on the Inside: Oral GLP-1s, Hormones, and a New Era for South Asian Women | Endocrine Matters Ep. 2.52

Thin on the Outside, Metabolic on the Inside: Oral GLP-1s, Hormones, and a New Era for South Asian Women | Endocrine Matters Ep. 2.52

Listen for free

View show details
About this listen
 Thin on the Outside, Metabolic on the Inside: Oral GLP-1s, Hormones, and a New Era for South Asian Women | Endocrine Matters Ep. 2.52"But you're so thin." If a doctor has ever said that to you while your blood sugar crept up, this episode is yours.You're the "slim" one in the family, and your labs say prediabetes anyway. Dr. Arti Thangudu, triple board-certified endocrinologist and founder of Complete Medicine, explains why South Asians develop metabolic disease at lower body weights, why standard BMI cutoffs were never built for us, and the tools our mothers never had: the new oral GLP-1 pills with cash prices starting around $150 a month, the early data on pairing menopausal hormone therapy with a GLP-1, and the kind of doctor who looks at the whole picture instead of shrugging. This one is for your sister, your cousin, your mom, and yes, your auntie group chat.🔍 This episode explores:🧩 The visit so many South Asian women know: creeping blood sugar, high triglycerides, low HDL, borderline blood pressure — and a confused doctor saying "But you're so thin"🧩 Thin on the outside, metabolic on the inside: why we carry more fat around the organs and in the liver even at a "normal" weight🧩 Why our beta cells get tired earlier (the beta cell burnout connection), and why health organizations recommend LOWER BMI thresholds for South Asians🧩 "I am done with the shrug": genetics are real, but so are the tools our mothers never had — CGMs, GLP-1s, open conversations about menopause🧩 The new kids on the block: oral GLP-1 pills — the Wegovy pill (oral semaglutide) and Foundayo (orforglipron), a once-a-day pill with no empty-stomach rules🧩 Her hypothesis, clearly labeled as one: lower-dose oral GLP-1s as a possible happy middle ground for South Asians with metabolic disease who don't have obesity — better insulin sensitivity, triglycerides, and heart risk with less weight loss🧩 The honest fine print: no good data yet on normal-weight South Asians, current approvals are for obesity/overweight with a weight-related condition, and anything beyond that is an off-label decision made carefully with a doctor who knows you🧩 The price piece: cash prices for the lowest oral doses starting around $150 a month — a real access change🧩 The menopause connection: why midlife can feel like "pouring gasoline on a fire" for SA metabolic health, and early observational data suggesting estrogen and GLP-1s may work well together🧩 Why this is not a seven-minute-visit conversation, and what direct care endocrinology changes🧩 Ending the martyrdom: honoring our mothers without repeating their sacrifice👩 This episode is for you if:You've been told "you're fine" while your labs said otherwiseYou're the slim one in the family with a family history of diabetes or heart diseaseYou've wondered whether the new GLP-1 pills are for someone like youYou're a South Asian woman heading into (or through) perimenopauseYou grew up watching your mother eat last, sleep least, and go last on every list⚖️ The bottom lineYou can be thin on the outside and metabolic on the inside — for South Asians, a normal BMI does not mean a normal metabolism. Ask for the labs, and ask about your waist, not just your weight. We have tools our mothers never had, and the data for our community is still coming, but the promise is real. Our mothers' sacrifice can end with us: find a doctor who sees you, and give your daughters shoulders to stand on.🎙 About the HostDr. Arti Thangudu is a triple board-certified physician in Internal Medicine, Endocrinology, and Obesity Medicine, a Menopause Society Certified Practitioner, and the founder of Complete Medicine, a direct-care practice built around time, transparency, and evidence.📚 Resources MentionedFDA approval of Foundayo (orforglipron): Lilly announcementFDA approval of the Wegovy pill (oral semaglutide); cash pricing from $149/month for the lowest dosesBeta Cell Burnout — earlier Endocrine Matters episodeDirect care, explained — Endocrine Matters Ep. 2.50Complete Medicine: https://www.sacomplete.comThis episode is sponsored by Complete Medicine and Hey Healthy🔗 Learn More / Connect🩺 Complete Medicine → https://www.sacomplete.com | Direct care with a doctor who actually has time for you📩 Newsletter + Blog → https://www.sacomplete.com/complete-medicine-blog | Weekly, plain-language hormone breakdowns🎙 Podcast → Endocrine Matters, new episodes on all major platforms📲 Instagram → https://www.instagram.com/drartithangudu | Daily myth-busting and real talk▶️ YouTube → https://www.youtube.com/@drartithangudu | Full episodes and shortsSubscribe, leave a review, and send this one to your sister, your cousin, your mom, and yes, your auntie group chat.🎙 About Endocrine MattersEndocrine Matters is a weekly podcast where endocrinologist Dr. Arti Thangudu breaks down hormones, metabolism, and the healthcare system in plain language. No hype. No ...
adbl_web_anon_alc_button_suppression_t1
No reviews yet